Phase 3 trials won’t be complete for years. There is a revolving door between the leadership at the FDA and Pfizer. Countries with high vaccination rates have not reported the expected reduction in cases or deaths. The non-pharmaceutical interventions adopted by some states appear to have no impact on outcomes when compared to states without them. FDA approval of Comirnaty, which nobody got, is a pretty transparent rhetorical stratagem. The guarantees of safety are testimonials from people who either provided material support in the creation of this virus or inflicted Microsoft on the world (I’m not sure which is worse).
You may not find these (non-exhaustive) reasons compelling, but I don’t think hesitancy is the result of some unnamed cabal of villains casting aspersions on the pure intentions of the American politburo and pharmaceutical industry.
You make a lot of claims here, but it doesn't seem that they are supported by data. Hospitalization rates and death rates since early summer are drastically different for the vaccinated than for the unvaccinated. Different policies in different US states are producing very different outcomes. You claimed otherwise but did not offer data; here's some data you might consider.
So I Brave searched “cdc weekly provisional counts of deaths by state and select cause 2020-2021”, and I got a useful table from the CDC that you may want to look at yourself. I summed deaths for all causes for FL and CA and divided by their population 39.5M and 21.5M respectively. Yep, FL has about 1.4x more deaths per capita than CA.
Then I downloaded the table for 2014-2019 and performed the same calculations. For that same period FL has … 1.4x more deaths per capita than CA. Maybe that has more to do with the age distribution of their respective populations rather than the wise rule of Gavin Newsome.
I don’t recommend letting journalists do your stats for you.
You may not find these (non-exhaustive) reasons compelling, but I don’t think hesitancy is the result of some unnamed cabal of villains casting aspersions on the pure intentions of the American politburo and pharmaceutical industry.